Back

De-escalation of the antithrombotic therapy is independently associated with low risk of total mortality in patients with acute coronary syndrome (ACS) in real practice

4 March 2019 (09:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute Coronary Syndromes: Pharmacotherapy Pharmacotherapy ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Ms Anastasia Rogozhina

City Clinical Hospital 51, Moscow (Russian Federation)

4 More presentations in this session

Presentation thumbnail
Professor L. Malinova (Saratov, RU)
Abstract Slides
Presentation thumbnail
Doctor A. Loaisiga (Mexico City, MX)
Abstract Slides
Presentation thumbnail
Doctor S. Diaz Lancha (Albacete, ES)
Abstract
Presentation thumbnail
Doctor V. Marinho (Coimbra, PT)

Access the full session

Session thumbnail
Poster Session 3 - Acute Coronary Syndromes: Pharmacotherapy

The Event

Event poster

Acute Cardiovascular Care 2019

4 March 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial
2 September 2019
thumbnail
Congress Presentation
De-escalating treatments and transitioning care in a cardiac intensive care units network
9 March 2024
thumbnail
Congress Presentation
Oral anticoagulation monotherapy versus combination antithrombotic therapy in patients with AF and PCI with a drug-eluting stent implantation: a systematic review and meta-analysis
23 April 2026
thumbnail
Webinar
The EAPCI Journal Club: T-PASS Randomised Trial
14 November 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources